Search Results

How Iowa's Prescription Drug Affordability Board affects patient access: statute, board actions, public Iowa PDAB Back to PDAB Policy Center Information, updates, and engagement opportunities related to the Statute: Pending before the Iowa Legislature, SF264 PDAB (includes public meeting notices): Iowa has CANN tracks proposed and pending legislation in Iowa and will update this page as the state's posture Other Healthcare Policy Areas in your state CANN monitors multiple healthcare policy initiatives across Iowa

Patient-centered tracking of 340B policy in Iowa: active bills, committee assignments, fact sheets, and Iowa 340B Watch Stay informed on state-level actions, proposed legislation, and advocacy efforts shaping Comments Letters, testimony, and press releases submitted regarding state 340B activity CANN Statement on Iowa's Million 340B Contract Pharmacy Scandal (April 2026) Publication Date: 4/24/26 Jen Laws responds to Iowa's View PDF Current Legislative Session Activity in Iowa No legislative activity in the 2026 session.

Blogs Read Our Latest Analysis When Oversight Fails: Iowa's $22 Million Contract Pharmacy Scandal and the Structural Fragility of ADAP Financing On March 6, 2026, the Iowa Department of Health and Human Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa

measures. 02/04/2026 Press Releases Document Title Document Summary Publication Date CANN Statement on Iowa's $22 Million 340B Contract Pharmacy Scandal (April 2026) Jen Laws responds to Iowa's ADAP crisis caused engagement via the PDAAC toolkit and Community Partner Network. 05/11/2026 Public Comment CANN Statement on Iowa's $22 Million 340B Contract Pharmacy Scandal (April 2026) Jen Laws responds to Iowa's ADAP crisis caused

Colorado Maryland New Jersey Connecticut Massachusetts Ohio Illinois Michigan Oregon Iowa Minnesota Vermont